CD8A and COVID-19: Our study indicates that while the neutrophil‐to‐CD8 ratio can be used as an early prognostic marker of COVID‐19 in‐ICU mortality, and, thus, to stratify the highest risk patients in ICU settings, the CD4‐to‐CD8 ratio might additionally be useful to identify a high‐risk population among currently‐healthy individuals.